Table 2.
The effect of prenatal vitamin D3 supplementation on the development of asthma/recurrent wheeze by age 0–3 years stratified by maternal 17q21 genotype.
| Mother rs12936231 genotype | VDAART | COPSAC2010 | ||||
|---|---|---|---|---|---|---|
| Cases/Total | HR (95% CI) | P value | Cases/Total | HR (95% CI) | P value | |
| GG/GC* | 127/431 | 0.54 (0.37–0.77) | <0.001 | 70/415 | 0.56 (0.35–0.92) | 0.021 |
| GG | 34/132 | 0.39 (0.18–0.83) | 0.015 | 25/152 | 0.51 (0.22–1.18) | 0.117 |
| GC | 93/299 | 0.58 (0.39–0.88) | 0.011 | 45/263 | 0.59 (0.33–1.08) | 0.086 |
| CC | 50/182 | 1.05 (0.61–1.84) | 0.853 | 30/148 | 1.11 (0.54–2.28) | 0.785 |
Combined maternal GG-genotype and GC-genotype.
Analyses were performed using Cox proportional hazard regression. G is considered as the dominant low-risk allele and C the recessive high-risk allele.